Parameswaran Hari

Parameswaran Hari

Company: Iovance Biotherapeutics

Job title: SVP, Clinical Science

Seminars:

Improving the Efficacy of Adoptive T Cell Therapy by Leveraging the Polyclonality of TIL 4:30 pm

• Efficacy of polyclonal TIL: current data in solid tumors • What’s next: genetically modified TIL • Ensuring success and access to TIL therapyRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.